Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Axogen Announces New VP of Operations and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Friday, 10'th Jan 2025
Craig Swandal, experienced medical device manufacturing executive, joins leadership team Craig Swandal, experienced medical device manufacturing executive, joins leadership team
Axogen: Well Placed To Capitalize Growth At Higher Multiples
08:01pm, Monday, 06'th Jan 2025
Axogen: Well Placed To Capitalize Growth At Higher Multiples
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
10:16am, Tuesday, 24'th Dec 2024
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is AxoGen (AXGN) Stock Outpacing Its Medical Peers This Year?
10:45am, Thursday, 19'th Dec 2024
Here is how AxoGen (AXGN) and Boston Scientific (BSX) have performed compared to their sector so far this year.
All You Need to Know About AxoGen (AXGN) Rating Upgrade to Buy
01:05pm, Thursday, 28'th Nov 2024
AxoGen (AXGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
How Much Upside is Left in AxoGen (AXGN)? Wall Street Analysts Think 31.18%
10:56am, Monday, 25'th Nov 2024
The mean of analysts' price targets for AxoGen (AXGN) points to a 31.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
Axogen, Inc (AXGN) Q3 2024 Earnings Call Transcript
09:53am, Saturday, 09'th Nov 2024
Axogen, Inc (NASDAQ:AXGN ) Q3 2024 Results Conference Call November 7, 2024 8:00 AM ET Company Participants Michael Dale - Chairman and Chief Executive Officer Nir Naor - Chief Financial Officer Confe
AxoGen (AXGN) Surges 8.2%: Is This an Indication of Further Gains?
08:29am, Monday, 14'th Oct 2024
AxoGen (AXGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t
First September Gains in 5 Years? Buy 3 Breakout Stocks Now
04:06pm, Monday, 23'rd Sep 2024
Bioventus, Great Lakes Dredge & Dock, and AxoGen have been selected as the breakout stocks for today.
Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®
07:00am, Friday, 06'th Sep 2024
ALACHUA, Fla. and TAMPA, Fla., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,
AxoGen, Inc. (AXGN) Hit a 52 Week High, Can the Run Continue?
10:16am, Wednesday, 04'th Sep 2024
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
What Makes AxoGen (AXGN) a Strong Momentum Stock: Buy Now?
01:01pm, Friday, 30'th Aug 2024
Does AxoGen (AXGN) have what it takes to be a top stock pick for momentum investors? Let's find out.
Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?
10:55am, Friday, 23'rd Aug 2024
The mean of analysts' price targets for AxoGen (AXGN) points to a 25.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts
AxoGen, Inc. (AXGN) Hits Fresh High: Is There Still Room to Run?
10:15am, Monday, 19'th Aug 2024
AxoGen (AXGN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Apple, Inc. (AXGN) Q2 2024 Earnings Call Transcript
02:10pm, Thursday, 08'th Aug 2024
AxoGen, Inc. (NASDAQ:AXGN ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Harold Tamayo - Vice President-Finance and Investor Relations Karen Zaderej - Chairman, Chie
